See more : Nippon Thompson Co., Ltd. (6480.T) Income Statement Analysis – Financial Results
Complete financial analysis of Halma plc (HLMAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Halma plc, a leading company in the Conglomerates industry within the Industrials sector.
You may be interested
- Tohbu Network Co., Ltd. (9036.T) Income Statement Analysis – Financial Results
- Helix Wind, Corp. (HLXW) Income Statement Analysis – Financial Results
- SAB Industries Limited (SAB.BO) Income Statement Analysis – Financial Results
- Zhejiang Yilida Ventilator Co.,Ltd. (002686.SZ) Income Statement Analysis – Financial Results
- kneat.com, inc. (KSI.TO) Income Statement Analysis – Financial Results
Halma plc (HLMAF)
About Halma plc
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.03B | 1.85B | 1.53B | 1.32B | 1.34B | 1.21B | 1.08B | 961.66M | 807.81M | 726.13M | 676.51M | 619.21M | 579.88M | 518.43M | 459.12M | 455.93M | 395.06M | 351.12M | 310.77M | 268.72M | 292.64M | 267.29M | 267.60M | 268.32M | 233.49M | 217.76M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost of Revenue | 1.03B | 974.90M | 801.00M | 704.60M | 707.10M | 644.80M | 540.67M | 482.82M | 408.97M | 342.87M | 321.99M | 297.70M | 285.01M | 345.84M | 310.53M | 313.84M | 266.58M | 236.58M | 207.44M | 208.06M | 205.12M | 187.01M | 189.02M | 187.97M | 163.50M | 152.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.00B | 877.90M | 724.30M | 613.60M | 631.30M | 566.10M | 535.54M | 478.84M | 398.83M | 383.26M | 354.52M | 321.51M | 294.88M | 172.59M | 148.59M | 142.09M | 128.48M | 114.54M | 103.33M | 60.66M | 87.52M | 80.29M | 78.57M | 80.35M | 69.99M | 65.63M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Gross Profit Ratio | 49.35% | 47.38% | 47.49% | 46.55% | 47.17% | 46.75% | 49.76% | 49.79% | 49.37% | 52.78% | 52.40% | 51.92% | 50.85% | 33.29% | 32.36% | 31.16% | 32.52% | 32.62% | 33.25% | 22.57% | 29.91% | 30.04% | 29.36% | 29.94% | 29.98% | 30.14% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 71.20M | 58.60M | 39.50M | 42.60M | 41.10M | 37.65M | 29.12M | 24.07M | 35.43M | 32.31M | 30.36M | 22.71M | 20.95M | 18.30M | 19.06M | 14.84M | 11.42M | 10.95M | 11.76M | 11.24M | 9.62M | 8.21M | 7.99M | 6.75M | 6.42M | 6.03M | 5.62M | 4.57M | 4.29M | 3.68M | 3.16M | 2.78M | 2.25M | 1.94M | 1.27M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.40M | 404.40M | 316.70M | 267.90M | 270.10M | 231.50M | 222.60M | 189.58M | 154.08M | 131.54M | 108.12M | 113.17M | 101.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 220.70M | 210.10M | 168.00M | 144.60M | 162.00M | 149.70M | 162.90M | 153.66M | 124.91M | 114.66M | 102.83M | 91.04M | 83.88M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 6.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 636.10M | 485.20M | 380.90M | 321.80M | 343.10M | 306.70M | 306.73M | 277.25M | 225.99M | 246.20M | 210.95M | 204.21M | 184.97M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 36.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.55M | -2.01M | -1.42M | -1.88M | -470.00K | 0.00 | 0.00 | -2.00M | -759.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.14M | 14.08M | 11.41M | 8.92M | 6.39M | 5.22M |
| Operating Expenses | 636.10M | 556.40M | 439.50M | 361.30M | 385.70M | 347.80M | 344.38M | 306.37M | 250.06M | 246.20M | 210.95M | 204.21M | 184.97M | 73.54M | 64.77M | 66.31M | 59.58M | 50.88M | 44.69M | 11.67M | 27.83M | 34.41M | 30.51M | 30.56M | 18.79M | 24.79M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost & Expenses | 1.67B | 1.53B | 1.24B | 1.07B | 1.09B | 992.60M | 885.05M | 789.19M | 659.03M | 589.07M | 532.94M | 501.91M | 469.97M | 419.38M | 375.30M | 380.15M | 326.16M | 287.45M | 252.13M | 219.73M | 232.95M | 221.41M | 219.53M | 218.53M | 182.29M | 176.92M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Interest Income | 3.10M | 700.00K | 200.00K | 800.00K | 600.00K | 400.00K | 255.00K | 211.00K | 217.00K | 134.00K | 252.00K | 195.00K | 9.74M | 317.00K | 189.00K | 643.00K | 721.00K | 1.04M | 1.03M | 5.66M | 995.00K | 1.22M | 820.00K | 708.00K | 1.09M | 1.62M | 1.00M | 845.00K | 1.09M | 874.00K | 719.00K | 1.36M | 1.06M | 1.10M | 929.00K | 222.00K | 319.00K | 213.00K | 247.00K |
| Interest Expense | 29.60M | 18.30M | 8.70M | 10.80M | 11.70M | 9.00M | 8.15M | 8.14M | 4.71M | 4.58M | 4.74M | 4.06M | 11.23M | 1.25M | 3.05M | 4.06M | 2.87M | 2.86M | 2.85M | 6.72M | 763.00K | 812.00K | 583.00K | 713.00K | 754.00K | 573.00K | 420.00K | 496.00K | 583.00K | 480.00K | 607.00K | 791.00K | 939.00K | 988.00K | 871.00K | 271.00K | 158.00K | 139.00K | 190.00K |
| Depreciation & Amortization | 105.60M | 101.50M | 88.60M | 90.30M | 84.70M | 66.20M | 62.31M | 57.65M | 44.90M | 40.68M | 36.31M | 31.90M | 27.67M | 21.73M | 21.23M | 20.34M | 15.88M | 13.13M | 11.34M | 9.32M | 7.88M | 7.55M | 7.37M | 7.02M | 6.25M | 5.75M | 5.33M | 4.99M | 4.40M | 4.01M | 3.53M | 2.96M | 2.51M | 2.23M | 1.80M | 1.44M | 1.13M | 935.00K | 756.00K |
| EBITDA | 475.50M | 410.60M | 373.40M | 342.60M | 320.60M | 282.30M | 243.20M | 224.04M | 187.39M | 178.87M | 179.73M | 148.41M | 150.87M | 121.27M | 105.36M | 97.19M | 85.58M | 78.15M | 70.83M | 63.99M | 59.04M | 51.64M | 53.91M | 55.50M | 50.77M | 47.87M | 47.97M | 42.57M | 38.60M | 33.72M | 29.21M | 24.64M | 17.67M | 16.47M | 16.81M | 13.07M | 10.37M | 7.54M | 6.22M |
| EBITDA Ratio | 23.38% | 22.83% | 24.48% | 25.99% | 24.68% | 23.49% | 23.55% | 23.93% | 23.98% | 24.43% | 26.58% | 23.97% | 25.35% | 23.40% | 22.95% | 21.24% | 21.66% | 22.17% | 22.85% | 23.81% | 20.17% | 20.47% | 21.02% | 21.44% | 21.74% | 22.14% | 22.44% | 21.40% | 22.28% | 21.99% | 21.70% | 21.30% | 20.33% | 20.12% | 21.52% | 21.39% | 20.40% | 20.45% | 19.98% |
| Operating Income | 367.70M | 321.50M | 284.80M | 252.30M | 245.60M | 218.30M | 191.16M | 172.47M | 148.78M | 137.06M | 143.57M | 117.30M | 109.91M | 99.45M | 84.30M | 76.21M | 70.17M | 63.98M | 58.46M | 49.02M | 46.21M | 42.80M | 45.72M | 47.77M | 42.14M | 40.50M | 41.81M | 36.73M | 33.11M | 28.84M | 24.96M | 20.33M | 15.50M | 14.24M | 15.01M | 11.63M | 9.24M | 6.60M | 5.47M |
| Operating Income Ratio | 18.08% | 17.35% | 18.67% | 19.14% | 18.35% | 18.03% | 17.76% | 17.93% | 18.42% | 18.88% | 21.22% | 18.94% | 18.95% | 19.18% | 18.36% | 16.71% | 17.76% | 18.22% | 18.81% | 18.24% | 15.79% | 16.01% | 17.09% | 17.80% | 18.05% | 18.60% | 19.56% | 18.35% | 19.07% | 18.76% | 18.45% | 17.50% | 16.39% | 17.40% | 19.22% | 19.04% | 18.18% | 17.91% | 17.55% |
| Total Other Income/Expenses | -27.40M | -30.00M | 25.60M | 600.00K | -16.00M | -11.10M | -15.30M | -9.37M | -11.82M | -3.45M | -4.89M | 2.12M | 2.06M | -1.16M | -2.92M | -3.42M | -2.14M | -1.83M | -1.82M | -1.05M | -9.30M | 474.00K | 237.00K | -5.00K | -7.44M | 1.05M | -5.18M | 349.00K | 509.00K | 394.00K | 112.00K | 565.00K | -1.28M | -988.00K | -871.00K | -271.00K | -158.00K | -139.00K | -190.00K |
| Income Before Tax | 340.30M | 291.50M | 304.50M | 252.90M | 224.20M | 206.80M | 172.26M | 157.78M | 136.45M | 133.61M | 138.68M | 120.14M | 111.97M | 98.29M | 81.37M | 72.79M | 68.02M | 62.15M | 56.64M | 47.96M | 36.92M | 43.27M | 45.96M | 47.76M | 34.70M | 41.55M | 36.63M | 37.08M | 33.62M | 29.23M | 25.08M | 20.89M | 14.22M | 13.26M | 14.14M | 11.36M | 9.08M | 6.46M | 5.28M |
| Income Before Tax Ratio | 16.73% | 15.73% | 19.96% | 19.19% | 16.75% | 17.08% | 16.01% | 16.41% | 16.89% | 18.40% | 20.50% | 19.40% | 19.31% | 18.96% | 17.72% | 15.96% | 17.22% | 17.70% | 18.23% | 17.85% | 12.61% | 16.19% | 17.17% | 17.80% | 14.86% | 19.08% | 17.13% | 18.53% | 19.36% | 19.02% | 18.53% | 17.99% | 15.04% | 16.19% | 18.10% | 18.60% | 17.87% | 17.54% | 16.94% |
| Income Tax Expense | 71.50M | 57.20M | 60.20M | 49.60M | 39.70M | 36.90M | 17.72M | 28.01M | 27.45M | 29.61M | 32.35M | 26.53M | 25.26M | 25.86M | 20.94M | 20.21M | 19.69M | 18.45M | 17.03M | 14.47M | 14.59M | 14.91M | 14.80M | 15.64M | 12.69M | 12.96M | 11.85M | 11.97M | 10.69M | 9.42M | 8.29M | 6.47M | 4.55M | 4.09M | 4.56M | 3.73M | 3.24M | 2.28M | 1.93M |
| Net Income | 268.80M | 234.50M | 244.40M | 203.40M | 184.40M | 169.80M | 154.20M | 129.69M | 108.84M | 104.00M | 106.33M | 93.61M | 86.71M | 72.43M | 60.44M | 52.58M | 50.28M | 44.01M | 40.88M | 34.55M | 22.32M | 28.36M | 31.16M | 32.12M | 22.01M | 28.59M | 24.78M | 25.10M | 22.93M | 19.81M | 16.79M | 14.40M | 9.67M | 8.08M | 10.43M | 7.93M | 5.84M | 3.69M | 3.33M |
| Net Income Ratio | 13.21% | 12.66% | 16.02% | 15.43% | 13.78% | 14.02% | 14.33% | 13.49% | 13.47% | 14.32% | 15.72% | 15.12% | 14.95% | 13.97% | 13.16% | 11.53% | 12.73% | 12.53% | 13.15% | 12.86% | 7.63% | 10.61% | 11.64% | 11.97% | 9.43% | 13.13% | 11.59% | 12.54% | 13.20% | 12.89% | 12.41% | 12.40% | 10.23% | 9.87% | 13.35% | 12.97% | 11.50% | 10.00% | 10.68% |
| EPS | 0.71 | 0.62 | 0.65 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| EPS Diluted | 0.71 | 0.62 | 0.64 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 377.30M | 378.00M | 378.70M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.33M | 377.81M | 377.60M | 376.93M | 376.61M | 375.49M | 373.83M | 372.77M | 371.22M | 369.05M | 368.18M | 366.24M | 365.41M | 363.10M | 360.65M | 361.34M | 360.97M | 359.99M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
| Weighted Avg Shares Out (Dil) | 378.70M | 379.10M | 379.40M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.48M | 378.04M | 378.01M | 377.47M | 377.37M | 376.51M | 374.89M | 374.60M | 374.04M | 370.44M | 368.70M | 366.24M | 365.92M | 364.84M | 361.10M | 362.20M | 362.26M | 361.43M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
3 Reasons You Should Stay The Course With Dividend Stocks
With bond yields at levels last seen before the Great Recession, it is difficult to argue against the attractiveness of fixed-income investments. However, it is extremely important to focus on the long term and consider three aspects before chasing the...
Halma: Great Company But Continues To Look Overvalued
Halma has a strong track record of dividend growth and operates in a defensive business area. The company expects good organic revenue growth despite negative market conditions in Asia Pacific. Halma's annual dividend has increased by at least 5% for...
TSI Group Joins Halma Group, Unveiling New Avenues for Growth
SUGAR LAND, Texas , Nov. 20, 2023 /PRNewswire/ -- TeDan Surgical Innovations, a leading player in the medical technology sector, is thrilled to announce its inclusion in the Halma Group. This strategic move marks the formation of the TSI Group, which...
Halma acquires TeDan healthcare companies
Halma PLC (LSE:HLMA) has announced the acquisition of surgical access systems manufacturer TeDan's four businesses for £72 million. Including TeDan Surgical Innovations Inc, West Coast Surgical, Axcess Surgical Innovations, TeDan Surgical Innovations GmbH, Halma said it had bought the TeDan...
Halma recovery continues after 'solid' half-year
Halma continued to recover from its recent four-year low with what brokers described as a solid set of interim numbers. All sectors in the engineer's portfolio, Safety, Environmental & Analysis, and Healthcare, saw revenues pick up helping the total overall...
Halma target cut but better placed than others, suggests UBS
Halma has seen its share price target slashed by analysts at Swiss bank UBS even though they acknowledge as companies go it is better insulated than most against an adverse economic cycle or even recession. Higher interest rates will put...
UK's Halma sees first-half return on sales at lower end of target
British health and safety device maker Halma on Thursday said it expects first-half return on sales to be at the lower end of its target range, hurt by weakness in its environmental and analysis unit.
Halma half-year update fails to impress market
Halma PLC (LSE:HLMA) shares fell after the safety products group released a solid first-half update amid "varied market conditions" and said its full-year expectations remained unchanged. For the six month period to 30 September, the FTSE 100-listed group said it expects...
Halma deals pipeline update to be first quarter highlight
Halma is one of those acquisition-led businesses, like Bunzl, that are very successful but need deals to flow to keep the wheels turning. As Matt Britzman, equity analyst at Hargreaves Lansdown, says: “Halma's essentially a mash-up of around 45 businesses...
Halma: Unleashing Growth Potential
Halma Plc is a global group of technology companies specializing in safety, healthcare, and environmental solutions. The company has achieved 20 straight years of record growth, driven by its impressive business model. Halma is a serial acquirer with deep expertise...
Source: https://incomestatements.info
Category: Stock Reports